Koninklijke Philips (NYSE:PHG) Issues Earnings Results, Misses Expectations By $0.01 EPS

Koninklijke Philips (NYSE:PHG) announced its quarterly earnings data on Wednesday. The technology company reported $0.54 earnings per share for the quarter, missing the consensus estimate of $0.55 by ($0.01), Zacks reports. Koninklijke Philips had a positive return on equity of 10.11% and a negative net margin of 1.83%.

Koninklijke Philips Stock Performance

Shares of PHG stock opened at $24.67 on Wednesday. The stock has a market cap of $23.18 billion, a PE ratio of -58.71, a price-to-earnings-growth ratio of 0.92 and a beta of 0.77. The stock has a 50-day moving average of $26.28 and a 200-day moving average of $28.20. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.16 and a quick ratio of 0.74. Koninklijke Philips has a one year low of $19.55 and a one year high of $32.91.

Analysts Set New Price Targets

A number of research firms recently weighed in on PHG. Jefferies Financial Group raised shares of Koninklijke Philips from an “underperform” rating to a “hold” rating in a research note on Tuesday, October 29th. StockNews.com cut shares of Koninklijke Philips from a “buy” rating to a “hold” rating in a research report on Thursday, November 14th. Five investment analysts have rated the stock with a hold rating and one has issued a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Hold”.

About Koninklijke Philips

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.